Rudolf Benz

8PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyLearning, motivation and emotionRegenerative medicine (incl. stem cells)Primary health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 26, 2025
Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial.

Adalgisa Condoluci, Ilaria Romano, Daniel Dietrich

|Oct 14, 2023
Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.

Kira-Lee Koster, Nora-Medea Messerich, Thomas Volken

|Mar 11, 2023
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.

Nora-Medea Messerich, Narasimha Rao Uda, Thomas Volken

|Jul 02, 2021
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine.

Ioannis Chanias, Kristina Stojkov, Gregor Th Stehle

|Dec 29, 2020
Survey on Recommended Health Care for Adult Patients with Myelodysplastic Syndromes Identifies Areas for Improvement.

Ioannis Chanias, C Matthias Wilk, Rudolf Benz

Pageof 2

Frequent Collaborators

2 joint publications

Georg Stüssi

2 joint publications

Adrian Schmidt

2 joint publications

Ulrike Bacher

2 joint publications

Nicolas Bonadies